Skip to main content
SpringerLink
Log in

The role of monoamine oxidase A in the metabolism and function of noradrenaline and serotonin

  • Chapter
IUPHAR 9th International Congress of Pharmacology

Abstract

Monoamine oxidase (MAO) inhibitors were among the first psychotropic drugs to be discovered and introduced into clinical use either alone or in combination with serotonin (5-hydroxytryptamine) (5-HT) precursors for the treatment of depressive illness (Youdim & Finberg, 1982). The result of MAO inhibition is that brain 5-HT and noradrenaline (NA) are elevated and the pharmacological effects of indirectly acting amines of dietary origin (e.g. tyramine and phenylethylamine) are potentiated, whether or not the indirectly acting amines are substrates for MAO. Perhaps the most common effect is the hypertensive response produced by dietary tyramine in individuals medicated with MAO inhibitors (MAOIs). Since this syndrome was first recognized in patients who ingested certain cheeses which contained high levels of tyramine, the syndrome is referred to as the ‘cheese effect’. The ‘cheese effect’ occurs because these indirectly acting amines, which are also substrates for the neurotransmitter uptake system, release noradrenaline (NA) into neuronal cytoplasm where it is normally deaminated by MAO before egress from the neurone occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • ASHKENAZI, R., FINBERG, J.P.M. & YOUDIM, M.B.H. (1983). Behavioural hyperactivity in rats with selective monoamine oxidase inhibitors and a selective 5- hydroxytryptamine uptake blocker, LM5008. Br. J. Pharmac, 79, 765–771.

    Article  Google Scholar 

  • ASK, A.L., HELLSTROM, W., NORRMAN, S., OGREN, S-O. & ROSS, S.B. (1982b). Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-methyl- phenylethylamine derivatives in the rat. Neuropharmaology, 21, 299–308.

    Article  Google Scholar 

  • ASK, A.L., HÖGBERG, K., SCHMIDT, L., KIESSLING, H. & ROSS S.B., (1982a). (+)-4-D-Dimethyl-amino-2,a -dimethylphenylethylamine [FLA 336 (+)], a selective inhibitor of the A form of monoamine oxidase in the rat brain. Biochem. Pharmac, 31, 1401–1410.

    Article  Google Scholar 

  • BEY, P., FOZARD, J., McDONALD, I., PALFREYMAN, M.G. & ZREILKA, M. (1983). MD 72145: A potent and selec tive inhibitor of MAO type B. Br. J. Pharmac., 81, 50P.

    Google Scholar 

  • COHEN, R.M., CAMPBELL, I.C., COHEN, M.R., TORDA, T., PICKAR, D., DIEVER, L.J. & MURPHY, D.L. (1980). Presynaptic noradrenergic regulation during depression and antidepressant drug treatment. J. Psych. Res., 3, 93–101.

    Article  Google Scholar 

  • COHEN, R.M., CAMPBELL, I.C., DAUPHIN, M., TALLMAN, J.F. & MURPHY, D.L. (1982). Changes in a and ß-recep- tor densities in rat brain as a result of treatment with monoamine oxidase-inhibiting antidepressants. Neuro pharmacology, 21, 293–298.

    Google Scholar 

  • DaPRADA, M., KELLER, R., KELLER, H.H. & HAEFELY, W.E. (1982). Neurochemical effects in vitro and in vivo of antidepressant RO11–1163, a specific and short- acting MAO-A inhibitor. In Monoamine Oxidase and Its Selective Inhibitors. Beckmann, H. & Riederer, P. (eds), pp. 231–245, Basel: Karger.

    Google Scholar 

  • ELKS, M.L., YOUNGBLOOD, W.W. & KIZER, J.S. (1979). Serotonin synthesis and release in brain slices: indepen dence of tryptophan. Brain Res., 172, 471–486.

    Article  Google Scholar 

  • FINBERG, J.P.M. & TENNE, M. (1982). Relationship be tween tyramine potentiation and selective inhibition of monoamine oxidase type A and type B in the rat vas deferens. Br. J. Pharmac, 77,13–21.

    Article  Google Scholar 

  • FINBERG, J.P.M., TENNE, M. & YOUDIM, M.B.H. (1981). Tyramine antagonistic properties of AGH1135, an ir reversible inhibitor of monoamine oxidase type B. Br. J. Pharmac. ,73, 65–74.

    Article  Google Scholar 

  • FINBERG, J.P.M. & YOUDIM, M.B.H. (1984). Reversible monoamine oxidase inhibitors and the cheese effect. In Monoamine Oxidase and Disease. Prospects for Therapy with Reversible Inhibitors. Tipton, K.F. & Strolin-Benedetti, M. (eds), London: Academic Press (in press).

    Google Scholar 

  • FOWLER, C.J. & TIPTON, K.F. (1982). Deamination of 5- hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J. Neurochem., 38, 733–739.

    Article  Google Scholar 

  • GLOWINSKI, J. (1975). Properties and functions of intraneuronal monoamine compartments in central aminergic neurons. In Handbook of Psychopharmacology. Iversen, L.L., Iversen, S.D. & Snyder, S.H. (eds), pp. 1399–1467, New York: Plenum.

    Google Scholar 

  • GREEN, A.R. (1981). Pharmacological studies on serotonin-mediated behaviour. J. Physiol. Paris, 77, 437–447.

    Google Scholar 

  • GREEN, A.R. & GRAHAME-SMITH, D.G. (1976). The effect of drugs on the process regulating the functional activity of brain 5-hydroxytryptamine. Nature, 260, 487–491.

    Article  Google Scholar 

  • GREEN, A.R. & YOUDIM, M.B.H. (1975). Effects of monoamine oxidase inhibition by clorgyline, deprenyl, or tranylcypromine on 5-HT concentration in rat brain and hyperactivity following subsequent tryptophan ad ministration. Br. J. Pharmac, 55, 415–422.

    Article  Google Scholar 

  • JANOWSKY, A.J., OKADA, F., MANIER, D.H., APPLEGATE, C, STERANKA, L. & SULSER, F. (1982). Role of serotonergic input in the regulation of the ß- adrenoceptor-coupled adenylate cyclase in brain. Science, 218, 900–901.

    Article  Google Scholar 

  • JANOWSKY, A.J., STIEANKA, L.R., GILLESPIE, D.D. & SULSER, F. (1982). Role of neuronal signal input in the down-regulation or central noradrenergic receptor function by antidepressant drugs. J. Neurochem., 39, 290–292.

    Article  Google Scholar 

  • JOHNSTON, J.P. (1968). Some observations upon a new inhibition of monoamine oxidase in brain tissue. Biochem. Pharmac, 17,1285–1297.

    Article  Google Scholar 

  • KALIR, A., SABBAGH, A. & YOUDIM, M.B.H. (1981). Irreversible suicide and reversible inhibitors of mono amine oxidase A and B. Br. J. Pharmac, 72, 55–64.

    Article  Google Scholar 

  • KNOLL, J. & MAGYAR, K. (1972). Some puzzling pharmacological effects of monoamine oxidase in hibitors. Adv. Biochem. Psychopharmac, 5, 393–408.

    Google Scholar 

  • LEVITT, P., PINTAR, J.E. & BREAKEFIELD, X.O. (1982). Immunocytochemical demonstration of monoamine oxidase B in both astrocytes and serotonergic neurons. Proc. natn. Acad. Sci. U.S.A., 79, 6385–6390.

    Article  Google Scholar 

  • MARTINI, A., BONOLLO, L., NICOLIS, F.B., SEGA, R. & PALERMA, A. (1981). Effects of caroxazone, a revers ible monoamine oxidase inhibitor on the pressor re sponse to oral tyramine in man. Br. J. din. Pharmac, 11, 611–620.

    Article  Google Scholar 

  • MENNINI, T., BORRONI, E., SAMANIN, R. & GARATCTNI, S. (1981). Evidence of the existance of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int., 3, 289–294.

    Article  Google Scholar 

  • MISHRA, R., GILLESPIE, D.D., YOUDIM, M.B.H. & SUL-SER, F. (1983). Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepin ephrine receptor-coupled adenylate cyclase system in rat cortex. Psychopharmacology, 81, 220–224.

    Article  Google Scholar 

  • MOROT-GAUDRY, Y., BOURGOIN, S. & HAMON, M. (1981). Kinetic characteristics of newly synthesized 3H- 5-HT in the brain of control and reserpinized mice. Evidence for the heterogenous distribution of 5-HT in serotonergic neurons. Naunyn-Schmiedeberg’s Arch. Pharmac, 316, 311–316.

    Article  Google Scholar 

  • NEFF, N.H. & FUENTES, J.A. (1976). The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms. In Monoamine Oxidase and its Inhibition. Wolstenholme, G.E.W. & Knight, J. (eds), pp. 163–182, Amsterdam: Elsevier.

    Google Scholar 

  • OLPE, H.R. & SCHELLENBERG, A. (1981). The sensitivity of cortical neurons to serotonin: effects of chronic treat ment with antidepressants, serotonin-uptake inhibitors and monoamine oxidase blocking drugs. J. Neural Transm., 51, 233–241.

    Article  Google Scholar 

  • ROSS, S.V. & KELDER, D. (1977). Efflux of 5- hydroxytryptamine from synaptosomes of rat cerebral cortex. Acta physiol. scand., 99, 27–36.

    Article  Google Scholar 

  • SAVAGE, D.D., MENDELS, J. & FRAZER, A. (1980). Monoamine oxidase inhibitors and serotonin uptake inhibitors-differential effects on (3H)-serotonin binding sites in rat brain. J. Pharmac. exp. Ther., 212, 259–265.

    Google Scholar 

  • SCOTT, J.A. & CREWS, F.T. (1983). Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment. J. Pharmac. exp. Ther., 224, 640–646.

    Google Scholar 

  • SHIELDS, P.J. & ECCLESTON, D. (1973). Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J Neurochem., 20,881–888.

    Article  Google Scholar 

  • SHORE, P.A. & GIACHETTI, A. (1978). Reserpine: basic and clinical pharmacology. In Handbook of Psychopharmacology. Iversen, L.L., Iversen, S.D. & Snyder, S.H. (eds), pp. 197–219, New York: Plenum.

    Chapter  Google Scholar 

  • SQUIRES, R. (1972). Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective in hibitors and thermostability. A comparison of eight mammalian species. Adv. Biochem. Psychopharmac, 5, 335–347.

    Google Scholar 

  • STROLIN BENEDETTI, M., BOUCHER, J., CARLSSON, A. & FOWLER, D.J. (1983). Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat. Biochem. Pharmac, 32, 47–52.

    Article  Google Scholar 

  • STROLIN BENEDETTI, M., DOSTERT, P., GUFFROY, C. & TIPTON, K.F. (1982). Partial or total protection from long acting monoamine oxidase inhibitors by new short- acting MAOIs of type A, MD 780515 and type B MD 780236. In Monoamine Oxidase and Its Selective Inhibitors. Beckmann, H. & Riederer, P. (eds), pp. 82–105. Basal: Karger.

    Google Scholar 

  • SULSER, F. (1983). Mode of action of antidepressant drugs. J. clin. Psychiatry, 44, 14–20.

    Google Scholar 

  • TIPTON, K.F., McCRODDEN, J.M., KALIR, A. & YOUDIM, M.B.H. (1982). Inhibition of rat liver monoamine oxidase by a-methyl and N-propargyl-amine derivatives. Biochem. Pharmac, 31, 1251–1257.

    Article  Google Scholar 

  • WALDMEIER, P.C., BAUMANN, P.A., DELINI-STULA, A., BERNASCONI, R., SIGG, K., BUECH, O. & FELNER, A.E. (1982). Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase. In Monoamine Oxidase and Its Selective Inhibitors. Beckman, H. & Riederer, P. (eds), pp. 31–52, Basel: Karger.

    Google Scholar 

  • WALINDER, J. (1983). Combination of tryptophan and MAO inhibitors, tricyclic antidepressants and selective 5-HT reuptake inhibitors. Adv. biol. Psychiatry, 10, 82–83.

    Google Scholar 

  • YOUDIM, M.B.H. (1977). Tyramine and psychiatric disor ders. In Neuroregulators in Psychiatric Disorders. Usdin, E., Barchas, J. & Hamberg, D. (eds), pp. 57–67, New York: Oxford University Press.

    Google Scholar 

  • YOUDIM, M.B.H. (1983). In vivo noradrenaline is a sub strate for rat brain monoamine oxidase A and B. Br. J. Pharmac, 79, 477–480.

    Article  Google Scholar 

  • YOUDIM, M.B.H. & ASHKENAZI, R. (1982). Regulation of 5-HT catabolism. In Serotonin in Biological Psychiatry. Ho, B.T., Schoolar, J.C. & Usdin, E. (eds), pp. 35–60, New York: Raven.

    Google Scholar 

  • YOUDIM, M.B.H., COLLINS, G.C.S. & SANDLER, M. (1969). Multiple forms of rat brain monoamine oxidase. Nature, 233, 626–628.

    Article  Google Scholar 

  • YOUDIM, M.B.H., COLLINS, G.G.S. & SANDLER, M. (1971). Monoamine oxidase, multiple forms and selec tive inhibitors. Biochem. J., 121, 34–35.

    Article  Google Scholar 

  • YOUDIM, M.B.H. & FINBERG, J.P.M. (1982). Monoamine oxidase inhibitor antidepressants. In Psychopharmacol ogy. YOUDIM, M.B.H. & FINBERG, J.P.M. (ed.), pp. 38–70, Amster dam; Excerpta Medica.

    Google Scholar 

  • YOUDIM, M.B.H. & FINBERG, J.P.M. (1984). Monoamine oxidase inhibitor antidepressants. In Psychopharmacol ogy. Grahame-Smith, D.G. (ed.), Amsterdam: Excerp ta Medica (in press).

    Google Scholar 

  • YOUDIM, M.B.H., FINBERG, J.P.M. & TIPTON, K.F. (1984). Monoamine oxidases. In Handbook of Experimental Pharmacology. Weiner, N. & Trendlenburg, U. (eds), Berlin: Springer Verlag (in press).

    Google Scholar 

  • ZSILLA, G., BARBACCIA, M.L., GANDOLFI, O., KNOLL, J. & COSTA, E. (1983). (-)-Deprenyl a selective ‘B’ in hibitor, increased (3H)-imipramine binding and decreases ß-adrenergic receptor function. Eur. J. Pharmac, 89, 111–118.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Technion-Faculty of Medicine, Department of Pharmacology, Rappaport Family Institute, Haifa, Israel

    M. B. H. Youdim & J. B. M. Finberg

  2. Laboratory of Cell Biology and Genetics, NIADDK, National Institutes of Health, Bethesda, MD, 20205, USA

    M. B. H. Youdim

  3. Section on Biochemical Pharmacology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20205, USA

    D. M. Kuhn & W. A. Wolf

Authors
  1. M. B. H. Youdim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. B. M. Finberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. M. Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. A. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

William Paton James Mitchell Paul Turner

Copyright information

© 1984 Macmillan Publishers Limited

About this chapter

Cite this chapter

Youdim, M.B.H., Finberg, J.B.M., Kuhn, D.M., Wolf, W.A. (1984). The role of monoamine oxidase A in the metabolism and function of noradrenaline and serotonin. In: Paton, W., Mitchell, J., Turner, P. (eds) IUPHAR 9th International Congress of Pharmacology. Palgrave, London. https://doi.org/10.1007/978-1-349-86029-6_30

Download citation

Publish with us

Policies and ethics

Search

Navigation